Carlsmed, Inc. earnings releases CARL

Annual Quarterly

Carlsmed, Inc. last reported quarterly results on Aug 5, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $18.9 million (+56.7% year over year) and diluted EPS of -$0.39. It usually reports 12–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 5, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 12–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 5, 2026
36 days after quarter end
Q2 FY2026
ended Jun 30, 2026
19
+56.7%
-11
-55.3%
-0.39
+73.5%
May 5, 2026
35 days after quarter end
Q1 FY2026
ended Mar 31, 2026
16
-9
-0.32
Jan 12, 2026
12 days after quarter end
Q4 FY2025
ended Dec 31, 2025
15
-9
-0.32
Nov 6, 2025
37 days after quarter end
Q3 FY2025
ended Sep 30, 2025
13
-9
-0.40
Aug 28, 2025
59 days after quarter end
Q2 FY2025
ended Jun 30, 2025
12
-7
-1.47

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
CARL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
, Emerging growth company
SEC CIK
1794546

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.